Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk | MicrobiomeTrials← Back to trialsNCT06845423
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-05-16Est. Completion: 2028-05-16
Enrollment target: 2,400 participants Locations- CHU d'Amiens Picardie, Amiens, France
- CHU de Bordeaux, Groupe Pellegrin, Centre Aliénor d'Aquitaine, Bordeaux, France
- CHU de Brest, Brest, France
- Hôpital Béclère, AP-HP, Clamart, France
- CHU de Clermont Ferrand Site Estaing, Clermont-Ferrand, France
- CH départemental de Vendée, La Roche-sur-Yon, France
- Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France
- Hôpital Nord Marseille, AP-HM, Marseille, France
- Centre Hospitalier des Pays de Morlaix, Morlaix, France
- CHRU de Nancy, Nancy, France
- CHU de Nantes, Nantes, France
- Hôpital Lariboisière, AP-HP, Paris, France
- Groupe Hospitalier Paris Saint Joseph, Paris, France
- CH de Pau, Pau, France
- Centre Hospitalier de Périgueux, Périgueux, France
- Centre Hospitalier de Cornouaille Quimper Concarneau, Quimper, France
- CHU de Rennes, Rennes, France
- CHU de St Etienne - Hôpital Nord, Saint-Priest-en-Jarez, France
Other microbiome trials you might be interested in
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patie…
Alexander City, United StatesEst. completion Oct 2029
StrokeDVTAnkle Contracture
Stroke is closely associated with high mortality among patients in hospitals and immobility leading development of deep …
Singapore, SingaporeCompleted Oct 31, 2023